LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System
November 25, 2024 | 19:00
Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings
Mobile Version